(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 4.4% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.56%.
Elanco Animal Health's revenue in 2026 is $5,020,000,000.On average, 18 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,579,547,508,290, with the lowest ELAN revenue forecast at $2,433,158,312,100, and the highest ELAN revenue forecast at $2,675,974,521,480. On average, 18 Wall Street analysts forecast ELAN's revenue for 2027 to be $2,715,944,267,880, with the lowest ELAN revenue forecast at $2,561,061,500,580, and the highest ELAN revenue forecast at $2,844,347,078,190.
In 2028, ELAN is forecast to generate $2,854,339,514,790 in revenue, with the lowest revenue forecast at $2,652,492,295,470 and the highest revenue forecast at $3,027,708,289,800.